Iagnosis raises $2.8M for consumer-facing dermatologist service

By Aditi Pai
11:53 am

DermOnCallIagnosis, parent company of virtual visit skin care company DermatologistOnCall, raised $2.8 million from undisclosed angel investors. This brings Iagnosis' total funding to date to $8.8 million.

Chief Strategy Officer and cofounder Larry Eakin told MobiHealthNews that he plans to use the funds for marketing efforts at DermatologistOnCall.

To use DermatologistOnCall, which offers online, tablet, or smartphone-based consultations, patients first fill out a questionnaire that verifies whether or not their issue is appropriate for online care. Once he or she is confirmed as a viable patient, they set up a profile with demographic info and other basic facts. After that, patients are matched with a doctor so that they can send pictures of the skin condition that needs treatment. Users pay $65 per consult and the information is sent to the dermatologist. Eakin said the average time patients wait to get a response is 10 hours. The max time users wait is 3.5 days. After the diagnosis, patients can message back and forth with the dermatologist for 30 days.

Dermatologists work with the company on a consulting basis and are not employees of DermatologistOnCall. The service is currently available in Pennsylvania, West Virginia, District of Columbia, Ohio, Florida, North Carolina, and Georgia, but Eakin hopes to reach half the states by the end of the year.

"There will be further announcements down the road where we will be partnering with major integrated delivery networks, large dermatology practices, things like that," Eakin said. "So it won't just be independent dermatologists, even though with dermatology, a lot of derms do have independent practices."

DermatologistOnCall plans to develop more channel partners across what he calls the "skincare value chain" too, with insurers, hospital system, pharamacy retailers, large dermatology groups, and large pharmaceutical companies.


The latest news in digital health delivered daily to your inbox.

Thank you for subscribing!
Error! Something went wrong!